Home  |  Contact

Cellosaurus Ma-10 (CVCL_7061)

[Text version]

Cell line name Ma-10
Synonyms Ma10
Accession CVCL_7061
Resource Identification Initiative To cite this cell line use: Ma-10 (RRID:CVCL_7061)
Comments Population: Japanese.
Doubling time: 75.0 hours (PubMed=1650680).
Sequence variations
Disease Lung adenocarcinoma (NCIt: C3512)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 57Y
Category Cancer cell line
Publications

PubMed=1650680; DOI=10.1378/chest.100.2.429
Masuda N., Fukuoka M., Takada M., Kudoh S., Kusunoki Y.
Establishment and characterization of 20 human non-small cell lung cancer cell lines in a serum-free defined medium (ACL-4).
Chest 100:429-438(1991)

PubMed=9393586; DOI=10.1007/s004320050101
Shimizu E., Zhao M., Shinohara A., Namikawa O., Ogura T., Masuda N., Takada M., Fukuoka M., Sone S.
Differential expressions of cyclin A and the retinoblastoma gene product in histological subtypes of lung cancer cell lines.
J. Cancer Res. Clin. Oncol. 123:533-538(1997)

PubMed=11005564; DOI=10.1038/sj.neo.7900094
Kohno T., Sato T., Takakura S., Takei K., Inoue K., Nishioka M., Yokota J.
Mutation and expression of the DCC gene in human lung cancer.
Neoplasia 2:300-305(2000)

PubMed=15802814; DOI=10.1248/bpb.28.707
Ikuta K., Takemura K., Sasaki K., Kihara M., Nishimura M., Ueda N., Naito S., Lee E., Shimizu E., Yamauchi A.
Expression of multidrug resistance proteins and accumulation of cisplatin in human non-small cell lung cancer cells.
Biol. Pharm. Bull. 28:707-712(2005)

PubMed=19472407; DOI=10.1002/humu.21028
Blanco R., Iwakawa R., Tang M., Kohno T., Angulo B., Pio R., Montuenga L.M., Minna J.D., Yokota J., Sanchez-Cespedes M.
A gene-alteration profile of human lung cancer cell lines.
Hum. Mutat. 30:1199-1206(2009)

PubMed=20557307; DOI=10.1111/j.1349-7006.2010.01622.x
Iwakawa R., Kohno T., Enari M., Kiyono T., Yokota J.
Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma.
Cancer Sci. 101:1891-1896(2010)

PubMed=22313637; DOI=10.4161/cbt.19238
Takata M., Chikumi H., Miyake N., Adachi K., Kanamori Y., Yamasaki A., Igishi T., Burioka N., Nanba E., Shimizu E.
Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity.
Cancer Biol. Ther. 13:369-378(2012)

Cross-references
Encyclopedic resources Wikidata; Q54903679
Polymorphism and mutation databases Cosmic; 801596
Cosmic; 844838
Cosmic; 876146
Cosmic; 917994
Cosmic; 1239875
Cosmic; 1656897
Cosmic; 2125272
Cosmic; 2668315
IARC_TP53; 11882
Entry history
Entry creation04-Apr-2012
Last entry update23-Sep-2021
Version number14